BI-1347 |
BI-1347 : Inhibitor of CDK8 and CDK19
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CDK8 |
|
|
| CDK19 |
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Invitrogen® panel: 369 kinases screened @ 10 µM
Selected IC50 measured @ Invitrogen®:
CDK8 IC50 = 1. ...
Potency Cellular
In Vitro
CDK8
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acsmedchemlett.9b00480
CDK19
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1158/1535-7163.MCT-19-0789
In Vivo Validations
Mouse
Dose: 1 mg/Kg IV, 10 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
15% QH
Bioavailability:
93%
Volume of Distribution at Steady-State:
0.5 L/Kg
Reference: --
Rat
Dose: 3 mg/Kg IV, 10 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
14% QH
Bioavailability:
69%
Volume of Distribution at Steady-State:
0.4 L/Kg
Reference: --
Negative Control Compounds
BI-1374
Notes: Inhibition of pSTAT S727 in NK-92 cells IC50> 10000 nM
SMILES:
CN(C)C(CN(N=C1)C=C1C(C=C2)=CC=C2C3=NN=C4C=CC=CN43)=O
Chemical Information
| Molecular Formula | C22H20N4O |
| SMILEs | CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1 |
| InChI | InChI=1S/C22H20N4O/c1-25(2)22(27)15-26-14-19(12-24-26)16-7-9-17(10-8-16)21-13-23-11-18-5-3-4-6-20(18)21/h3-14H,15H2,1-2H3 |
| Molecular weight | 356.16 Da |
| AlogP | 3.853500000000002 |
| HBond acceptors | 5 |
| HBond donors | -- |
| Atoms | 47 |